Icatibant Acetate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Icatibant Acetate Injection (injection) from Fresenius Kabi USA, LLC with status To Be Discontinued. The shortage was first posted on 05/07/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-574-93
- Dosage Form
- Injection
- Presentation
- Icatibant Acetate, Injection, 10 mg/1 mL (NDC 63323-574-93)
- Initial Posting
- 05/07/2026
- Revised Date